Washington, May 10 (ANI): A new study has uncovered the potential of oncolytic viruses in killing cancer stem cells, particularly in the case of the fatal pancreatic cancer.
Oncolytic viruses are naturally occurring viruses that have been genetically engineered to be safe and express tracking genes, as a possible therapy against pancreatic cancer stem cells.
Researchers have found that oncolytic virus quickly infects and kills cancer stem cells, paving the way for treatment of tumours that are resistant to conventional chemotherapy and radiation.
It has emerged that cancer stem cells are thought to cause disease recurrence and metastasis, even after therapy and oncolytic viruses may offer a new treatment strategy.
"What we learned is that oncolytic viruses have been engineered to selectively target cancer cells and have a low toxicity profile in animal studies," said Joyce Wong, surgical researcher with Memorial Sloan-Kettering Cancer Center.
"Targeting the cancer stem cell may enhance our ability to eradicate tumours and prevent future recurrence of disease," he added. (ANI)
|
|
Read More: Cancer
Comments:
